<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Maria</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Laiteerapong, Neda</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Using the Legacy Effect to Improve Patient Outcomes</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-07-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">21-22</style></pages><abstract><style  face="normal" font="default" size="100%">Among individuals with diabetes, early intensive glycemic control is associated with long-term benefits 10 or more years later (ie, the legacy effect) [Holman RR et al. N Engl J Med 2008]. This article discusses the clinical implications of the legacy effect and the lag time before additional antihyperglycemic agents are added.</style></abstract><number><style face="normal" font="default" size="100%">19</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>